CI - Cigna Crushes Q1 Estimates: Revenue Soars With Evernorth's Explosive Growth | Benzinga
On Thursday, Cigna Corporation (NYSE:CI) reported first-quarter sales of $57.26 billion, up 23% Y/Y, beating the consensus of $55.47 billion, primarily driven by significant growth in Evernorth Health Services, reflecting several large client wins.
Adjusted income from operations increased 16% to $1.88 billion, reflecting strong contributions from Cigna Healthcare and Evernorth Health Services.
Cigna Healthcare sales increased 4% Y/Y to $13.3 billion, reflecting premium rate increases to cover expected increases in underlying medical costs and business mix.
Also Read: Arthritis Patients – Cigna’s Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost.
Cigna’s ...